bcl-2 antisense oligodeoxynucleotide G3139
Term · Oncology and biomedicine · MLC-T-ONC-000953
A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, Genasense, and oblimersen sodium.
| Identifier | MLC-T-ONC-000953 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | augmerosen; Genasense; oblimersen sodium |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000953",
"term": "bcl-2 antisense oligodeoxynucleotide G3139",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, Genasense, and oblimersen sodium.",
"synonyms": [
"augmerosen",
"Genasense",
"oblimersen sodium"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/bcl-2-antisense-oligodeoxynucleotide-g3139/"
}
Record 3,339 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.